OrbiMed Secures $3 Billion for Global and Asia Private Equity Funds

OrbiMed, a prominent player in global healthcare investment, has successfully raised $3 billion in commitments for two new private equity funds. The funds, named OrbiMed Private Investments X and OrbiMed Asia Partners VI, focus on life sciences and healthcare growth opportunities.

OrbiMed Private Investments X gathered over $1.9 billion for U.S. and European ventures in life sciences. OrbiMed Asia Partners VI raised more than $1 billion targeting health-related growth across Asia. Both funds aim to foster leading firms in biopharmaceuticals, medical devices, diagnostics, and tech-enabled healthcare services.

The initiative has attracted investments from diverse entities including medical institutions and financial foundations. With a team of over 150 experts, OrbiMed continues to expand from its 12 international locations.